Microbot Medical (NASDAQ:MBOT – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ...
March 04, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the appointment of Pa Research ...
BRAINTREE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, today announced the appointment of ...
EDT Microbot Medical (MBOT) files to sell 12.54M shares of common stock for holdersOptimize Your Investment Research with ...
4.4% of Nemaura Medical shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by ...
Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative single use LIBERTY® Endovascular Robotic System, today announced that it has submitted a 510(k) premarket notification to the U.S ...
March 04, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, today announced the appointment of Paul Mullen, a seasoned ...